# Suxiao Jiuxin Pills in Microvascular Obstruction in Patients With Acute Coronary Syndrome

Study · id `cardio:ct-nct04814121` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04814121](<https://clinicaltrials.gov/study/NCT04814121>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04814121

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 198 participants.

## Technical summary

Registry record NCT04814121. Randomized; quadruple masking; primary purpose treatment. Start 2021-05-01 (anticipated); primary completion 2023-09-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 198 participants (planned count; ClinicalTrials.gov record NCT04814121, source copy `cardio:ctgov-nct04814121-2021-03-24`, retrieved 2026-10-31)
- Planned start: 2021-05-01 (anticipated) (ClinicalTrials.gov record NCT04814121, source copy `cardio:ctgov-nct04814121-2021-03-24`, retrieved 2026-10-31)
- Primary completion: 2023-09-30 (anticipated) (ClinicalTrials.gov record NCT04814121, source copy `cardio:ctgov-nct04814121-2021-03-24`, retrieved 2026-10-31)
- Completion: 2023-09-30 (anticipated) (ClinicalTrials.gov record NCT04814121, source copy `cardio:ctgov-nct04814121-2021-03-24`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04814121-2021-03-24`, retrieved 2026-10-31)

## The registry's words

- Brief title: Suxiao Jiuxin Pills in Microvascular Obstruction in Patients With Acute Coronary Syndrome
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Suxiao Jiuxin Pills
- Intervention (Drug): The placebo of Suxiao Jiuxin Pills
- Lead sponsor: Guangzhou University of Traditional Chinese Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: Guangzhou University of Traditional Chinese Medicine (`cardio:org-guangzhou-university-of-traditional-chinese-medicine`)

## Provenance

Content hash: 5b32a849ed7cc0ddb04542d1676fef79ee8eb8a588dbb5246073167a3c4292f5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
